References

M. Y. Speer, H.-Y. Yang, T. Brabb, E. Leaf, A. Look, W.-L. Lin, A. Frutkin, D. Dichek, and C. M. Giachelli, “Smooth Muscle Cells Give Rise to Osteochondrogenic Precursors and Chondrocytes in Calcifying Arteries,” Circulation Research, vol. 104, no. 6, pp. 733–741, May 2009.

I. Kurnatowska, P. Grzelak, A. Masajtis-Zagajewska, M. Kaczmarska, L. Stefańczyk, C. Vermeer, K. Maresz, and M. Nowicki, “Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3–5,” Polish Archives of Internal Medicine, vol. 125, no. 9, pp. 631–640, 2015.

M. H. J. Knapen, Lavienja A. J. L. M. Braam, N. E. Drummen, O. Bekers, A. P. G. Hoeks, and C. Vermeer, “Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women,” Thrombosis and Haemostasis, vol. 113, no. 05, pp. 1135–1144, 2015.

M. J. H. V. Summeren, Lavienja A. J. L. M. Braam, M. R. Lilien, L. J. Schurgers, W. Kuis, and C. Vermeer, “The effect of menaquinone-7 (vitamin K2) supplementation on osteocalcin carboxylation in healthy prepubertal children,” British Journal of Nutrition, vol. 102, no. 08, p. 1171, 2009.

K. Motohara, S. Takagi, F. Endo, Y. Kiyota, and I. Matsuda, “Oral Supplementation of Vitamin K for Pregnant Women and Effects on Levels of Plasma Vitamin K and PIVKA-II in the Neonate,” Journal of Pediatric Gastroenterology and Nutrition, vol. 11, no. 1, pp. 32–36, 1990.

H. Katsuyama, S. Ideguchi, M. Fukunaga, K. Saijoh, and S. Sunami, “Usual Dietary Intake of Fermented Soybeans (Natto) Is Associated with Bone Mineral Density in Premenopausal Women.,” Journal of Nutritional Science and Vitaminology, vol. 48, no. 3, pp. 207–215, 2002.

M. Møller, I. M. F. Gjelstad, I. Baksaas, T. Grande, I. R. Aukrust, and C. A. Drevon, “Bioavailability and Chemical/Functional Aspects of Synthetic MK-7 vs Fermentation-Derived MK-7 in Randomised Controlled Trials,” International Journal for Vitamin and Nutrition Research, pp. 1–15, Apr. 2016.

A. A. Poundarik, T. Diab, G. E. Sroga, A. Ural, A. L. Boskey, C. M. Gundberg, and D. Vashishth, “Dilatational band formation in bone,” Proceedings of the National Academy of Sciences, vol. 109, no. 47, pp. 19178– 19183, May 2012.

G. Gast, N. D. Roos, I. Sluijs, M. Bots, J. Beulens, J. Geleijnse, J. Witteman, D. Grobbee, P. Peeters, and Y. V. D. Schouw, “A high menaquinone intake reduces the incidence of coronary heart disease,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 19, no. 7, pp. 504–510, 2009.

H. J. Choi, J. Yu, H. Choi, J. H. An, S. W. Kim, K. S. Park, H. C. Jang, S. Y. Kim, and C. S. Shin, “Vitamin K2 Supplementation Improves Insulin Sensitivity via Osteocalcin Metabolism: A Placebo-Controlled Trial,” Diabetes Care, vol. 34, no. 9, 2011.

D. K. Cundiff and P. S. Agutter, “Cardiovascular Disease Death Before Age 65 in 168 Countries Correlated Statistically with Biometrics, Socioeconomic Status, Tobacco, Gender, Exercise, Macronutrients, and Vitamin K,” Cureus, 2016.

BK. McFarlin, et al. “Oral Consumption of Vitamin K2 for 8 Weeks Associated With Increased Maximal Cardiac Output During Exercise.” Altern Ther Health Med. 2017 vol. 23, no. 4, pp.26-32. 2017. Feb;59(2):186-95.

F. Oury, L. Khrimian, C. A. Denny, A. Gardin, A. Chamouni, N. Goeden, Y.-Y. Huang, H. Lee, P. Srinivas, X.-B. Gao, S. Suyama, T. Langer, J. J. Mann, T. L. Horvath, A. Bonnin, and G. Karsenty, “Maternal and Offspring Pools of Osteocalcin Influence Brain Development and Functions,” Cell, vol. 155, no. 1, pp. 228–241, 2013.

Y. Gat, M. Gornish, M. Heiblum, and S. Joshua, “Reversal of benign prostate hyperplasia by selective occlusion of impaired venous drainage in the male reproductive system: novel mechanism, new treatment,” Andrologia, vol. 40, no. 5, pp. 273–281, 2008.

C. Cario-Toumaniantz, C. Boularan, L. J. Schurgers, M.-F. Heymann, M. L. Cunff, J. Léger, G. Loirand, and P. Pacaud, “Identification of Differentially Expressed Genes in Human Varicose Veins: Involvement of Matrix Gla Protein in Extracellular Matrix Remodeling,” Journal of Vascular Research, vol. 44, no. 6, pp. 444–459, 2007.

D. Turck, et al. “Dietary Reference Values for vitamin K.” EFSA Journal, vol. 15, no.6 pp 4780, 2017.

I. Riphagen, et al. “Prevalence and Effects of Functional Vitamin K Insufficiency: The PREVEND Study.” Nutrients, vol. 9, no. 12, p. 1334. Aug 2017.

C. Brown. “Canadian Data Provide Window on Statin Use.” Canadian Medical Association Journal, vol. 188, no. 5, 2016, pp. 325–325.

E. Theuwissen, et al. “Vitamin K Status in Healthy Volunteers.” Food Funct., vol. 5, no. 2, 2014, pp. 229–234.

H. Okuyama, P. H. Langsjoen, N. Ohara, Y. Hashimoto, T. Hamazaki, S. Yoshida, T. Kobayashi, and A. M. Langsjoen, “Medicines and Vegetable Oils as Hidden Causes of Cardiovascular Disease and Diabetes,” Pharmacology, vol. 98, no. 3-4, pp. 134–170, 2016.

M. K. Shea, C. J. Odonnell, C. Vermeer, E. J. P. Magdeleyns, M. D. Crosier, C. M. Gundberg, J. M. Ordovas, S. B. Kritchevsky, and S. L. Booth, “Circulating Uncarboxylated Matrix Gla Protein Is Associated with Vitamin K Nutritional Status, but Not Coronary Artery Calcium, in Older Adults,” The Journal of Nutrition, vol. 141, no. 8, pp. 1529–1534, 2011.

S. Lamon-Fava. “Statins and Lipid Metabolism.” Current Opinion in Lipidology, vol. 24, no. 3, pp. 221–226, 2013.

M. J. Shearer, X. Fu, and S. L. Booth, “Vitamin K Nutrition, Metabolism, and Requirements: Current Concepts and Future Research,” Advances in Nutrition, vol. 3, no. 2, pp. 182–195, Jan. 2012.

P. Newman and M. J. Shearer, “Metabolism and cell biology of vitamin K,” Thrombosis and Haemostasis, vol. 100, no. 10, pp. 530–547, 2008.

L. J. Schurgers and C. Vermeer, “Differential lipoprotein transport pathways of K-vitamins in healthy subjects,” Biochimica et Biophysica Acta (BBA) – General Subjects, vol. 1570, no. 1, pp. 27–32, 2002.

T. Sato, L. J. Schurgers, and K. Uenishi, “Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women,” Nutrition Journal, vol. 11, no. 1, Dec. 2012.

T. Dayspring, “Postprandial and Fasting Lipids,” http:// www.lipidcenter.com/pdf/Postprandial_and_Fasting_ Lipids.pdf.2018.

P. Newman, F. Bonello, A. S. Wierzbicki, P. Lumb, G. F. Savidge, and M. J. Shearer, “The Uptake of Lipoprotein- Borne Phylloquinone (Vitamin K1) by Osteoblasts and Osteoblast-Like Cells: Role of Heparan Sulfate Proteoglycans and Apolipoprotein E,” Journal of Bone and Mineral Research, vol. 17, no. 3, pp. 426–433, Jan. 2002.

H. Okuyama, P. H. Langsjoen, T. Hamazaki, Y. Ogushi, R. Hama, T. Kobayashi, and H. Uchino, “Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms,” Expert Review of Clinical Pharmacology, vol. 8, no. 2, pp. 189–199, Jun. 2015.

A. Takeuchi et al., “Minimal effective dose of vitamin K2 (Menaquinone-4) on serum osteocalcin concentration in Japanese subjects and safety evaluation of vitamin K2 supplemented in calcium tablet,” Journal of Japan Society of Nutrition and Food Sciences, vol. 26, pp. 254–260, 2005.

N. Inaba, T. Sato, and T. Yamashita, “Low-Dose Daily Intake of Vitamin K2 (Menaquinone-7) Improves Osteocalcin γ-Carboxylation: A Double- Blind, Randomized Controlled Trials,” Journal of Nutritional Science and Vitaminology, vol. 61, no. 6, pp. 471–480, 2015.

L. J. Schurgers, K. J. F. Teunissen, K. Hamulyak, M. H. J. Knapen, H. Vik, and C. Vermeer, “Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7,” Blood, vol. 109, no. 8, pp. 3279–3283, 2007.

M. H. J. Knapen, L. J. Schurgers, and C. Vermeer, “Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women,” Osteoporosis International, vol. 18, no. 7, pp. 963–972, Aug. 2007.